Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(14):1051-1052;
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Siang, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siang, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 14, 1051-1052, July 18, 2001
© 2001 Oxford University Press

NEWS

International Clinical Trial Recommendations Released

Sanyin Siang

GoThe increasing number of U.S.-sponsored or -regulated trials conducted abroad, the changing landscape of international research collaborations, and potential exploitation of participants from developing countries have prompted the National Bioethics Advisory Commission to issue several recommendations regarding the conduct of research in other countries.


Figure Removed (Available Only in the Full Text)
View larger version (115K):
[in this window]
[in a new window]
 

 
Released earlier this year, the report focused on principal ethical requirements for U.S.-sponsored or -regulated clinical trials conducted in developing countries and the need for such research to be responsive to the health needs of the host country.

The report’s 23 recommendations . . . [Full Text of this Article]

Key Recommendations

‘Best Current’ Therapies

Ethics Infrastructure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?